Citation: S. Viergutz et al., A COMPARISON OF THE COST-EFFECTIVENESS OF PANTOPRAZOLE IN TREATING PEPTIC-ULCER DISEASE IN 6 EUROPEAN COUNTRIES, Gastroenterology, 114(4), 1998, pp. 1326-1326
Citation: S. Viergutz et al., COST-EFFECTIVENESS OF PANTOPRAZOLE IN PATIENTS WITH PEPTIC-ULCER DISEASE IN FRANCE, Gastroenterology, 114(4), 1998, pp. 1327-1327
Citation: Ku. Kirchgassler et al., CROSS-COUNTRY ADAPTATION OF PHARMACO-ECONOMIC EVALUATIONS - THE EXAMPLE OF MICRONIZED FENOFIBRATE AND SIMVASTATIN, Atherosclerosis, 134(1-2), 1997, pp. 52-52
Authors:
CULSHAW K
VIERGUTZ S
STEEN H
SCHOOK E
SCHLANDER M
Citation: K. Culshaw et al., TREATMENT OF PEPTIC-ULCER DISEASE WITH PANTOPRAZOLE - A COST-EFFECTIVENESS ANALYSIS IN THE NETHERLANDS, Gut, 41, 1997, pp. 98-98
Authors:
VIERGUTZ S
CULSHAW K
NETTEL H
SCHLANDER M
Citation: S. Viergutz et al., COMPARATIVE-ANALYSIS OF THE COST-EFFECTIVENESS OF PANTOPRAZOLE, RANITIDINE AND OMEPRAZOLE IN AUSTRIA USING DECISION-ANALYSIS, Gut, 41, 1997, pp. 98-99
Authors:
VIERGUTZ S
MALFERTHEINER P
GATZ G
SCHLANDER M
Citation: S. Viergutz et al., THE COST-EFFECTIVENESS OF HELICOBACTER-PYLORI ERADICATION WITH DUAL AND TRIPLE THERAPY, Gastroenterology, 110(4), 1996, pp. 286-286